Author + information
White HD, Chew DP, Hoekstra JW, et al. Safety and efficacy of switching from either unfractionated heparin or enoxaparin to bivalirudin in patients with non–ST-segment elevation acute coronary syndromes managed with an invasive strategy: Results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial. J Am Coll Cardiol 2008;51:1734–41.
In this article, the disclosures for Dr. Chadwick D. Miller were omitted. The full disclosures are below:
Dr. Miller is receiving or has received research support from Schering-Plough Research, Biosite, Millennium/Schering-Plough Research, Heartscape Inc., and Johnson & Johnson/Scios, Inc.; has received lecture fees from Genentech; and has served as a consultant to The Medicines Company, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, and Molecular Insight.
- American College of Cardiology Foundation